Merck (MRK) PT Lowered to $64 at Bernstein
Bernstein lowered its price target on Merck (NYSE: MRK) to $64.00 (from $65.00) while maintaining a Outperform rating.
Analyst Tim Anderson defends the name noting he continues to view the IO landscape as a "fluid one" and notes risks to IO forecasts are slowing which yields a modest LT EPS growth pattern overtime.